Literature DB >> 18347113

Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.

Sho Takahata1, Yoshihisa Kato, Yumiko Sanbongi, Kazunori Maebashi, Takashi Ida.   

Abstract

Horizontal transfer of the mutated ftsI gene from beta-lactamase-nonproducing ampicillin-resistant (BLNAR) Haemophilus influenzae to a susceptible strain was examined in vitro under selection with nine oral beta-lactams (ampicillin, amoxicillin, cefprozil, cefuroxime, cefpodoxime, cefdinir, cefcapene, cefditoren, and tebipenem). Compared to the penicillins and the carbapenem, the cephalosporins showed a wide selection window for the genetic transfer.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18347113      PMCID： PMC2346623          DOI： 10.1128/AAC.00936-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.

Authors:  James A Karlowsky; Ian A Critchley; Renée S Blosser-Middleton; Elena A Karginova; Mark E Jones; Clyde Thornsberry; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan.

Authors:  Kenji Suzuki; Tadao Nishimura; Shunkichi Baba
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

3.  In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.

Authors:  M Hikida; K Itahashi; A Igarashi; T Shiba; M Kitamura
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

4.  Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States.

Authors:  Keiko Hasegawa; Kentarou Yamamoto; Naoko Chiba; Reiko Kobayashi; Kensuke Nagai; Michael R Jacobs; Peter C Appelbaum; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

5.  In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.

Authors:  S Miyazaki; T Hosoyama; N Furuya; Y Ishii; T Matsumoto; A Ohno; K Tateda; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

6.  Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001.

Authors:  R Blosser-Middleton; D F Sahm; C Thornsberry; M E Jones; P A Hogan; I A Critchley; J A Karlowsky
Journal:  Clin Microbiol Infect       Date:  2003-05       Impact factor: 8.067

7.  The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Authors:  Michael R Jacobs; David Felmingham; Peter C Appelbaum; Reuben N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2003-07-15       Impact factor: 5.790

8.  Possible high rate of transmission of nontypeable Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, between children and their parents.

Authors:  Hiroshi Watanabe; Kazuhiko Hoshino; Rinya Sugita; Norichika Asoh; Kiwao Watanabe; Kazunori Oishi; Tsuyoshi Nagatake
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.

Authors:  Mihaela Peric; Frederick A Browne; Michael R Jacobs; Peter C Appelbaum
Journal:  Clin Ther       Date:  2003-01       Impact factor: 3.393

10.  Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae.

Authors:  Henri Dabernat; Catherine Delmas; Martine Seguy; Roseline Pelissier; Genevieve Faucon; Safia Bennamani; Christophe Pasquier
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
View more
  4 in total

1.  Design, synthesis, and evaluation of prodrugs of ertapenem.

Authors:  Sheo B Singh; Diane Rindgen; Prudence Bradley; Lovji Cama; Wanying Sun; Michael J Hafey; Takao Suzuki; Nengxue Wang; Hao Wu; Basheng Zhang; Li Wang; Chongmin Ji; Hongshi Yu; Richard Soll; David B Olsen; Peter T Meinke; Deborah A Nicoll-Griffith
Journal:  ACS Med Chem Lett       Date:  2013-07-03       Impact factor: 4.345

2.  Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae.

Authors:  Natalia González; Lorenzo Aguilar; David Sevillano; Maria-Jose Giménez; Luis Alou; Fabio Cafini; Martha Torrico; Ana-Maria López; Pilar Coronel; Jose Prieto
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

3.  Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.

Authors:  Lorenzo Aguilar; María-José Giménez; José Barberán
Journal:  Infect Drug Resist       Date:  2010-06-18       Impact factor: 4.003

Review 4.  [Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections].

Authors:  R Menéndez; R Cantón; A García-Caballero; J Barberán
Journal:  Rev Esp Quimioter       Date:  2019-12-04       Impact factor: 1.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.